[go: up one dir, main page]

FR2736837B1 - Dispositif pour l'administration, par electrotransport transdermique, de fentanyl ou de sufentanil - Google Patents

Dispositif pour l'administration, par electrotransport transdermique, de fentanyl ou de sufentanil

Info

Publication number
FR2736837B1
FR2736837B1 FR9606916A FR9606916A FR2736837B1 FR 2736837 B1 FR2736837 B1 FR 2736837B1 FR 9606916 A FR9606916 A FR 9606916A FR 9606916 A FR9606916 A FR 9606916A FR 2736837 B1 FR2736837 B1 FR 2736837B1
Authority
FR
France
Prior art keywords
sufentanil
fentanyl
administration
transdermal electrotransport
electrotransport
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9606916A
Other languages
English (en)
Other versions
FR2736837A1 (fr
Inventor
Joseph B Phipps
Mary Southam
Keith J Bernstein
Henk Noorduin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23848034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2736837(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of FR2736837A1 publication Critical patent/FR2736837A1/fr
Application granted granted Critical
Publication of FR2736837B1 publication Critical patent/FR2736837B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
FR9606916A 1995-06-05 1996-06-05 Dispositif pour l'administration, par electrotransport transdermique, de fentanyl ou de sufentanil Expired - Fee Related FR2736837B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/465,492 US6881208B1 (en) 1995-06-05 1995-06-05 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil

Publications (2)

Publication Number Publication Date
FR2736837A1 FR2736837A1 (fr) 1997-01-24
FR2736837B1 true FR2736837B1 (fr) 1998-07-24

Family

ID=23848034

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9606916A Expired - Fee Related FR2736837B1 (fr) 1995-06-05 1996-06-05 Dispositif pour l'administration, par electrotransport transdermique, de fentanyl ou de sufentanil

Country Status (20)

Country Link
US (3) US6881208B1 (fr)
JP (3) JPH11506684A (fr)
KR (1) KR100431364B1 (fr)
CN (1) CN1118308C (fr)
AT (1) AT409088B (fr)
AU (1) AU695465B2 (fr)
BE (1) BE1009505A3 (fr)
BR (1) BR9609137B1 (fr)
CA (2) CA2613061C (fr)
CH (1) CH690751A5 (fr)
DE (1) DE19681420B4 (fr)
FR (1) FR2736837B1 (fr)
GB (1) GB2317115B (fr)
GR (1) GR1002982B (fr)
IE (1) IE960374A1 (fr)
IT (1) IT1285387B1 (fr)
NL (1) NL1003274C2 (fr)
SE (1) SE521220C2 (fr)
WO (1) WO1996039224A1 (fr)
ZA (1) ZA964658B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US6195582B1 (en) 1998-01-28 2001-02-27 Alza Corporation Electrotransport device electrode assembly having lower initial resistance
US6858018B1 (en) 1998-09-28 2005-02-22 Vyteris, Inc. Iontophoretic devices
DE69937647T2 (de) 1998-11-02 2008-10-30 Alza Corp., Mountain View Iontophoretische vorrichtung mit einem materialverträglichen antimikrobiellen wirkstoff
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6496727B1 (en) * 2000-05-31 2002-12-17 Becton, Dickinson And Company Medicament-loaded transdermal reservoir and method for its formation
KR20080053423A (ko) 2000-07-31 2008-06-12 니코메드 댄마크 에이에스 코 투여용 펜타닐 조성물
MXPA03002177A (es) * 2000-09-11 2004-12-13 Johnson & Johnson Dispositivo de electrotransporte transdermico y metodo para fabricar el mismo.
AU2002303239C1 (en) 2001-04-04 2006-11-09 Alza Corporation Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2004002571A1 (fr) * 2002-06-28 2004-01-08 Alza Corporation Reservoir utilise dans un dispositif de distribution de medicament par electrotransport
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
US20080009782A1 (en) * 2006-06-28 2008-01-10 Alza Corporation Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
KR100730582B1 (ko) * 2006-11-20 2007-06-20 아람휴비스(주) 이온토포레시스 장치
US20080154230A1 (en) * 2006-12-20 2008-06-26 Janardhanan Anand Subramony Anode for electrotransport of cationic drug
EP2043733A1 (fr) * 2007-06-26 2009-04-08 Alza Corporation Procédés et dispositifs d'administration de lofentanil et de carfentanil par électrotransport transdermique
US20090105634A1 (en) * 2007-10-17 2009-04-23 Alza Corporation Anodic Reservoir for Electrotransport of Cationic Drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride
WO2009123970A2 (fr) * 2008-04-01 2009-10-08 Alza Corporation Dispositif de distribution de fentanyl par électrotransport à distribution constante
WO2009158032A1 (fr) * 2008-06-25 2009-12-30 Fe2, Inc. Patchs et procédés d'administration transdermique d'une quantité thérapeutiquement suffisante de fer
US20100004583A1 (en) * 2008-07-01 2010-01-07 Alza Corporation Hydrophobic Circuit Board Coating of Electrotransport Drug Delivery Devices
MX2011002373A (es) * 2008-09-02 2011-06-20 Travanti Pharma Inc Diseño de electrodos de sacrificio y especies de administracion adecuadas para periodos de aplicacion prolongados de iontoforesis.
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US8983594B2 (en) 2008-12-30 2015-03-17 Nupathe, Inc. Electronic control of drug delivery system
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
WO2010107761A1 (fr) 2009-03-18 2010-09-23 Acelrx Pharmaceuticals, Inc. Dispositifs de stockage et de distribution améliorés pour l'administration de formes posologiques transmucosales orales
US8821945B2 (en) * 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
CN102458567B (zh) * 2009-04-25 2015-04-08 因卡伯实验室有限责任公司 螯合药剂的透皮离子电渗递送方法
US8903485B2 (en) 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
WO2011130455A1 (fr) 2010-04-13 2011-10-20 Najib Babul Compositions pharmaceutiques dermiques de 1-méthyl-2',6'-pipécoloxylidide et méthode d'utilisation
CN103228318B (zh) 2010-11-23 2016-03-23 泰华制药国际有限公司 使用者激活的自包含共封装的离子透入给药系统
WO2012129576A2 (fr) * 2011-03-24 2012-09-27 Incube Labs, Llc Système et procédé d'administration iontophorétique transdermique biphasique d'agents thérapeutiques
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
WO2012154704A2 (fr) 2011-05-06 2012-11-15 Incube Labs, Llc Système et procédé d'administration transdermique iontophorétique biphasique d'agents thérapeutiques, dans la régulation des états de manque dus à l'accoutumance
DE112013002074T5 (de) 2012-04-17 2015-01-29 Purdue Pharma L.P. Systeme und Methoden zur Behandlung einer Opioid-induzierten unerwünschten pharmakodynamischen Reaktion
SG11201704797TA (en) 2014-12-23 2017-07-28 Acelrx Pharmaceuticals Inc Systems, devices and methods for dispensing oral transmucosal dosage forms

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5135479A (en) 1983-08-18 1992-08-04 Drug Delivery Systems, Inc. Programmable control and mounting system for transdermal drug applicator
US5224928A (en) 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US5135477A (en) 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4752285B1 (en) 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) * 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US5006108A (en) 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US5320597A (en) 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5232448A (en) 1989-12-05 1993-08-03 Prime Medical Products Patient-controlled analgesia device
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
IT1244030B (it) 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5125894A (en) * 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
AU657681B2 (en) * 1990-03-30 1995-03-23 Alza Corporation Device and method for iontophoretic drug delivery
US5224927A (en) 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US5254081A (en) 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5464387A (en) * 1991-07-24 1995-11-07 Alza Corporation Transdermal delivery device
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
US5298017A (en) 1992-12-29 1994-03-29 Alza Corporation Layered electrotransport drug delivery system
US7027859B1 (en) * 1994-09-26 2006-04-11 Alza Corporation Electrotransport delivery device having improved safety and reduced abuse potential
US5879322A (en) * 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
US6216033B1 (en) * 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil

Also Published As

Publication number Publication date
CA2613061C (fr) 2010-02-09
NL1003274C2 (nl) 1998-11-03
DE19681420T1 (de) 1998-05-20
ZA964658B (en) 1997-02-03
AU6257896A (en) 1996-12-24
IE960374A1 (en) 1996-12-11
CA2219736A1 (fr) 1996-12-12
US20050171464A1 (en) 2005-08-04
KR100431364B1 (ko) 2004-07-16
SE521220C2 (sv) 2003-10-14
BR9609137A (pt) 1999-02-17
JP4616309B2 (ja) 2011-01-19
IT1285387B1 (it) 1998-06-03
JP2007237002A (ja) 2007-09-20
GB2317115A (en) 1998-03-18
BE1009505A3 (fr) 1997-04-01
ITTO960477A1 (it) 1997-12-03
FR2736837A1 (fr) 1997-01-24
JP4070779B2 (ja) 2008-04-02
CH690751A5 (de) 2001-01-15
US6881208B1 (en) 2005-04-19
GR1002982B (el) 1998-10-01
DE19681420B4 (de) 2009-05-28
CN1118308C (zh) 2003-08-20
AU695465B2 (en) 1998-08-13
KR19990022342A (ko) 1999-03-25
SE9704103D0 (sv) 1997-11-10
JP2005261970A (ja) 2005-09-29
WO1996039224A1 (fr) 1996-12-12
ITTO960477A0 (it) 1996-06-03
JPH11506684A (ja) 1999-06-15
GR960100178A (el) 1997-02-28
GB2317115B (en) 1999-08-04
CA2613061A1 (fr) 1996-12-12
ATA903696A (de) 2001-10-15
CA2219736C (fr) 2008-02-12
AT409088B (de) 2002-05-27
SE9704103L (sv) 1997-11-10
US20050131337A1 (en) 2005-06-16
NL1003274A1 (nl) 1996-12-06
BR9609137B1 (pt) 2010-06-29
CN1187142A (zh) 1998-07-08
GB9725542D0 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
FR2736837B1 (fr) Dispositif pour l'administration, par electrotransport transdermique, de fentanyl ou de sufentanil
ITTO960469A0 (it) Dispositivo per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
FR2734728B1 (fr) Dispositif pour l'administration de fentanyl ou de sufentanil par electrotransport transdermique
FR2709670B1 (fr) Dispositif en trois modules pour l'administration transdermique de médicaments par électrophorèse ou iontophorèse.
FR2704743B1 (fr) Dispositif pour réduire la sensation de douleur.
FR2567761B1 (fr) Dispositif d'apport transdermique pour l'administration de fentanyl
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
FR2732223B1 (fr) Composition pharmaceutique pour administration transdermique
FR2696074B1 (fr) Dispositif therapeutique en forme d'os pour chiens.
DE69633645D1 (de) Vorrichtung zum Verabreichen von Medikamenten
ZA9610729B (en) Transdermal device for the delivery of flurbiprofen.
FR2676913B1 (fr) Dispositif d'ablation de matiere, notamment pour la dentisterie.
FI955259L (fi) Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
EP1008365A4 (fr) Dispositif pour iontophorese
EP0601058A4 (fr) Formulations transdermiques pour l'administration de prazosine.
FI962220L (fi) Transdermaalinen terapeuttinen järjestelmä
DE69628672D1 (de) Transdermale verabreichung von risperidon mit kontrollierter geschwindigkeit
FR2704137B1 (fr) Dispositif d'osteosynthese pour rachis.
FR2738142B1 (fr) Dispositif d'ancrage pour reinsertion musculaire ou tendineuse
EP0823256A4 (fr) Medicament preventif ou therapeutique, ou les deux, pour les affections ischemiques
FR2735800B1 (fr) Dispositif de balisage de deviation pour autoroute ou autres voies routieres rapides
FR2716109B1 (fr) Dispositif d'hydromassage pour baignoire ou analogue.
FR2678514B1 (fr) Dispositif pour l'absorption dermique de solutes medicamenteux.
KR970031119U (ko) 운전자의 졸음방지장치
ITMI930820A0 (it) Dispositivo di comando dell'acceleratore per autovetture per disabili

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130228